Christopher Bowden Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Bowden.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Bowden. Christopher Bowden is Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Chief Medical Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in MIRAGEN THERAPEUTICS, INC. ($MGEN).
Latest Insider Trading Transactions of Christopher Bowden
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, MGEN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Option Exercise | A | 4.31 | 31,250 | 134,688 | 31,250 | |
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Grant | A | 0.00 | 4,167 | 0 | 4,167 | 0 to 4.2 K |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 39.76 | 1,888 | 75,067 | 43,332 | |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 12,513 | 439,957 | 0 | |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 3,210 | 112,864 | 12,513 | |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 55.11 | 14,401 | 793,582 | 15,487 | 29.9 K to 15.5 K (-48.18 %) |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 39.76 | 1,888 | 75,067 | 29,888 | 28 K to 29.9 K (+6.74 %) |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 12,513 | 439,957 | 28,000 | 15.5 K to 28 K (+80.80 %) |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 55.16 | 3,210 | 177,055 | 15,487 | 18.7 K to 15.5 K (-17.17 %) |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 3,210 | 112,864 | 18,697 | 15.5 K to 18.7 K (+20.73 %) |
| Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,334 | 0 | 3,333 | |
| Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 986 | 0 | 15,410 | 16.4 K to 15.4 K (-6.01 %) |
| Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 3,334 | 0 | 16,396 | 13.1 K to 16.4 K (+25.52 %) |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 0 | |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 4,000 | 0 | 8,000 | |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 2,069 | 0 | 13,062 | 15.1 K to 13.1 K (-13.67 %) |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 15,131 | 12.4 K to 15.1 K (+22.21 %) |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 4,000 | 0 | 12,381 | 8.4 K to 12.4 K (+47.73 %) |
| Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 56.68 | 44,000 | 2,493,920 | 44,000 | |
| Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| May 22 2020 | MGEN | MIRAGEN THERAPEUTI ... | Bowden Christopher | Director | Option Exercise | A | 0.63 | 24,000 | 15,026 | 24,000 | |
| May 21 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 3,583 | 125,978 | 15,723 | |
| May 21 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.01 | 3,583 | 179,200 | 8,306 | 11.9 K to 8.3 K (-30.14 %) |
| May 21 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 3,583 | 125,978 | 11,889 | 8.3 K to 11.9 K (+43.14 %) |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,280 | 0 | 10,561 | |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 40.64 | 2,368 | 96,236 | 8,230 | 10.6 K to 8.2 K (-22.34 %) |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 5,280 | 0 | 10,598 | 5.3 K to 10.6 K (+99.29 %) |
| Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
| Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 48.66 | 1,596 | 77,661 | 5,318 | 6.9 K to 5.3 K (-23.08 %) |
| Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 3,333 | 0 | 6,914 | 3.6 K to 6.9 K (+93.07 %) |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 52.01 | 819 | 42,596 | 3,581 | 4.4 K to 3.6 K (-18.61 %) |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 4,400 | 1.7 K to 4.4 K (+166.67 %) |
| Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 621 | 21,834 | 26,406 | |
| Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.02 | 621 | 31,063 | 1,650 | 2.3 K to 1.7 K (-27.34 %) |
| Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 621 | 21,834 | 2,271 | 1.7 K to 2.3 K (+37.64 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 35,447 | 1,246,317 | 27,027 | |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 8,526 | 299,774 | 62,474 | |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.10 | 35,447 | 1,776,026 | 1,650 | 37.1 K to 1.7 K (-95.55 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 35,447 | 1,246,317 | 37,097 | 1.7 K to 37.1 K (+2,148.30 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.03 | 14,191 | 709,963 | 1,650 | 15.8 K to 1.7 K (-89.58 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 8,526 | 299,774 | 15,841 | 7.3 K to 15.8 K (+116.56 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 | |
| Oct 29 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Option Exercise | A | 4.26 | 94,031 | 400,572 | 94,031 | |
| Jun 21 2019 | MGEN | MIRAGEN THERAPEUTI ... | Bowden Christopher | Director | Option Exercise | A | 2.36 | 12,000 | 28,320 | 12,000 | |
| Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 10,000 | 351,600 | 71,000 | |
| Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 68.72 | 100 | 6,872 | 7,238 | 7.3 K to 7.2 K (-1.36 %) |
| Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 68.09 | 1,500 | 102,135 | 7,338 | 8.8 K to 7.3 K (-16.97 %) |
| Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 66.85 | 2,546 | 170,200 | 8,838 | 11.4 K to 8.8 K (-22.36 %) |
| Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 66.03 | 5,854 | 386,540 | 11,384 | 17.2 K to 11.4 K (-33.96 %) |
| Apr 03 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 10,000 | 351,600 | 17,238 | 7.2 K to 17.2 K (+138.16 %) |
| Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 10,000 | 351,600 | 81,000 | |
| Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 64.64 | 1,300 | 84,032 | 7,238 | 8.5 K to 7.2 K (-15.23 %) |
| Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 64.09 | 8,700 | 557,583 | 8,538 | 17.2 K to 8.5 K (-50.47 %) |
| Mar 19 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 10,000 | 351,600 | 17,238 | 7.2 K to 17.2 K (+138.16 %) |
| Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 58.86 | 40,000 | 2,354,400 | 40,000 | |
| Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
| Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 58.03 | 818 | 47,469 | 7,195 | 8 K to 7.2 K (-10.21 %) |
| Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 8,013 | 5.3 K to 8 K (+52.25 %) |
| Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 6,265 | 0 | 0 | |
| Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 52.82 | 1,960 | 103,527 | 5,229 | 7.2 K to 5.2 K (-27.26 %) |
| Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 6,265 | 0 | 7,189 | 924 to 7.2 K (+678.03 %) |
| Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 1,700 | 59,772 | 91,000 | |
| Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 300 | 10,548 | 92,700 | |
| Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 80.03 | 1,700 | 136,051 | 924 | 2.6 K to 924 (-64.79 %) |
| Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 1,700 | 59,772 | 2,624 | 924 to 2.6 K (+183.98 %) |
| Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 80.00 | 300 | 24,000 | 924 | 1.2 K to 924 (-24.51 %) |
| Aug 31 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 300 | 10,548 | 1,224 | 924 to 1.2 K (+32.47 %) |
| Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,265 | 0 | 6,265 | |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 93,000 | |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 87.26 | 800 | 69,808 | 924 | 1.7 K to 924 (-46.40 %) |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 86.42 | 1,200 | 103,704 | 1,724 | 2.9 K to 1.7 K (-41.04 %) |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,924 | 924 to 2.9 K (+216.45 %) |
| Jun 28 2018 | MGEN | MIRAGEN THERAPEUTI ... | Bowden Christopher | Director | Option Exercise | A | 6.46 | 12,000 | 77,520 | 12,000 | |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 95,000 | |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 93.37 | 200 | 18,674 | 881 | 1.1 K to 881 (-18.50 %) |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 92.84 | 1,800 | 167,112 | 1,081 | 2.9 K to 1.1 K (-62.48 %) |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| May 10 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 99,000 | |
| May 10 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 81.38 | 2,000 | 162,760 | 881 | 2.9 K to 881 (-69.42 %) |
| May 10 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 101,000 | |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 85.68 | 700 | 59,976 | 881 | 1.6 K to 881 (-44.28 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 84.78 | 1,300 | 110,214 | 1,581 | 2.9 K to 1.6 K (-45.12 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 103,000 | |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 82.90 | 300 | 24,870 | 881 | 1.2 K to 881 (-25.40 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 82.23 | 1,700 | 139,791 | 1,181 | 2.9 K to 1.2 K (-59.01 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 6,000 | 210,960 | 109,000 | |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 65.00 | 6,000 | 390,000 | 881 | 6.9 K to 881 (-87.20 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 6,000 | 210,960 | 6,881 | 881 to 6.9 K (+681.04 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
| Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 39.76 | 45,220 | 1,797,947 | 177,220 | |
| Jun 02 2015 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 5,000 | 175,800 | 132,000 | |
| Jun 02 2015 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 120.67 | 5,000 | 603,350 | 0 | 5 K to 0 (-100.00 %) |
| Jun 02 2015 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 5,000 | 175,800 | 5,000 | 0 to 5 K |
| Mar 03 2015 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 107.89 | 17,000 | 1,834,130 | 137,000 | |
| Jun 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 35.16 | 120,000 | 4,219,200 | 120,000 |
Page: 1